Cancer testis antigen expression in testicular germ cell tumorigenesis

[1]  C. Schneider,et al.  MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs , 2011, Cell Death and Differentiation.

[2]  A. Wilkie,et al.  OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia , 2011, The Journal of pathology.

[3]  G. Kristiansen,et al.  MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer , 2011, PloS one.

[4]  H. Moch,et al.  Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients , 2011, PloS one.

[5]  G. Kristiansen,et al.  MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors , 2011, Modern Pathology.

[6]  J. Shipley,et al.  Testicular germ cell tumours: predisposition genes and the male germ cell niche , 2011, Nature Reviews Cancer.

[7]  T. Hupp,et al.  Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. , 2010, Cancer research.

[8]  L. Lacombe,et al.  High frequency of MAGE‐A4 and MAGE‐A9 expression in high‐risk bladder cancer , 2009, International journal of cancer.

[9]  A. S. Juncker,et al.  Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. , 2009, Cancer research.

[10]  H. Moch,et al.  Frequent expression of the novel cancer testis antigen MAGE‐C2/CT‐10 in hepatocellular carcinoma , 2009, International journal of cancer.

[11]  N. Probst-Hensch,et al.  MAGE‐C1/CT‐7 expression in plasma cell myeloma: Sub‐cellular localization impacts on clinical outcome , 2008, Cancer science.

[12]  E. Rajpert-De Meyts,et al.  From Gonocytes to Testicular Cancer , 2007, Annals of the New York Academy of Sciences.

[13]  D. Jäger,et al.  NY‐ESO‐1 protein expression in primary breast carcinoma and metastases—correlation with CD8+ T‐cell and CD79a+ plasmacytic/B‐cell infiltration , 2007, International journal of cancer.

[14]  L. Old,et al.  Expression of cancer-testis (CT) antigens in placenta. , 2007, Cancer immunity.

[15]  A. Simpson,et al.  Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2. , 2006, Cancer immunity.

[16]  G. Bartsch,et al.  Metastatic spermatocytic seminoma--an extremely rare disease. , 2006, European urology.

[17]  R. Pfundt,et al.  Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. , 2006, Cancer research.

[18]  Lloyd J. Old,et al.  Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.

[19]  M. J. van den Bent,et al.  Diagnostic value of OCT3/4 for pre‐invasive and invasive testicular germ cell tumours , 2005, The Journal of pathology.

[20]  L. Looijenga,et al.  Testicular germ-cell tumours in a broader perspective , 2005, Nature Reviews Cancer.

[21]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[22]  Liang Cheng,et al.  OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  A. Ruffion,et al.  Le séminome spermatocytaire: Étude anatomo-clinique et immunohistochimique de 7 cas , 2004 .

[24]  N. Berger,et al.  [Spermatocytic seminoma. A clinicopathological and immunohistochemical study of 7 cases]. , 2004, Annales de pathologie.

[25]  T. Boon,et al.  MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. , 2004, Nucleic acids research.

[26]  J. Bartek,et al.  The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE‐A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma , 2003, Histopathology.

[27]  Yao-Tseng Chen,et al.  Cancer/testis antigens: an expanding family of targets for cancer immunotherapy , 2002, Immunological reviews.

[28]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[29]  P. Chomez,et al.  MAGE‐A4, a germ cell specific marker, is expressed differentially in testicular tumors , 2001, Cancer.

[30]  O. Ogawa,et al.  Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. , 2001, The Journal of urology.

[31]  T. Boon,et al.  MAGE‐B5, MAGE‐B6, MAGE‐C2, and MAGE‐C3: four new members of the MAGE family with tumor‐specific expression , 2000, International journal of cancer.

[32]  Yao-Tseng Chen,et al.  Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours , 2000, British Journal of Cancer.

[33]  Yao-Tseng Chen,et al.  CT10: A new cancer‐testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational‐difference analysis , 2000, International journal of cancer.

[34]  J. Cheville,et al.  MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[35]  H. Miyake,et al.  Expression of MAGE genes in testicular germ cell tumors. , 1999, Urology.

[36]  M. Hirohata,et al.  Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. , 1995, Cancer research.

[37]  E. R. Meyts,et al.  Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours , 1994 .

[38]  J. Eble.  Spermatocytic seminoma. , 1994, Human pathology.

[39]  N. Skakkebaek,et al.  Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. , 1994, International journal of andrology.

[40]  N. Skakkebaek,et al.  Epidemiological and clinical aspects of carcinoma in situ of the testis. , 1993, European urology.

[41]  A. Giwercman,et al.  Placental‐like alkaline phosphatase as a marker of carcinoma‐in‐situ of the testis. Comparison with monoclonal antibodies M2A and 43–9F , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[42]  N. Skakkebaek,et al.  Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. , 1989, The Journal of urology.

[43]  D. Ondruš,et al.  Metastatic spermatocytic seminoma. A case report with light microscopic, ultrastructural, and immunohistochemical findings , 1988, Cancer.

[44]  N. Skakkebaek,et al.  Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. , 1987, International journal of andrology.

[45]  N. Skakkebaek,et al.  Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. , 1986, British medical journal.

[46]  N. Skakkebaek,et al.  Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. , 1985, The Journal of pediatrics.

[47]  C. Coffin,et al.  Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features. , 1985, Archives of pathology & laboratory medicine.

[48]  T. Lerut,et al.  THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS , 1985, The Lancet.

[49]  A. Talerman.  GERM CELL TUMOURS , 1985, Annales de pathologie.

[50]  Dong Seok Kim,et al.  GERM CELL TUMOURS , 2014, The Ulster Medical Journal.

[51]  G. Jacobsen,et al.  Carcinoma in situ of testicular tissue adjacent to malignant germ‐cell tumors: A study of 105 cases , 1981, Cancer.

[52]  C. Lewis,et al.  Metastatic spermatocytic seminoma. , 1980, The Journal of urology.

[53]  A. Talerman.  Spermatocytic seminoma. Clinicopathological study of 22 cases , 1980, Cancer.

[54]  N. Skakkebæk,et al.  HIGH INCIDENCE OF UNDETECTED NEOPLASIA IN MALDESCENDED TESTES , 1979, The Lancet.

[55]  P. W. Adams,et al.  VITAMIN B6, DEPRESSION, AND ORAL CONTRACEPTION , 1974 .

[56]  N. Skakkebæk.  POSSIBLE CARCINOMA-IN-SITU OF THE TESTIS , 1972 .